GERALDINE HENWOOD

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jillian Dilmore, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GERALDINE HENWOOD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Baudax Bio, Inc. President and CEO, Director Common Stock 2,427 $6,183 $2.55 15 Dec 2022 Direct
Baudax Bio, Inc. President and CEO, Director Common Stock 14 $36 $2.55 15 Dec 2022 By spouse
Recro Pharma, Inc. Director Stock Option (right to buy) 38,012 20 Apr 2021 Direct

Insider Reports Filed by GERALDINE HENWOOD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299322024038-henwood-geraldine-2022-12-15 Baudax Bio, Inc. 15 Dec 2022 1 +$3,057 4 President and CEO, Director 19 Dec 2022, 07:09
/report/000106299322015123-henwood-geraldine-2022-06-15 Baudax Bio, Inc. 15 Jun 2022 1 $0 4 President and CEO, Director 17 Jun 2022, 16:10
/report/000089924321049629-henwood-geraldine-2021-12-15 Baudax Bio, Inc. 15 Dec 2021 2 -$5,777 4 President and CEO, Director 23 Dec 2021, 16:45
/report/000089924321048181-henwood-geraldine-2021-12-05 Baudax Bio, Inc. 05 Dec 2021 1 -$3,204 4 President and CEO, Director 14 Dec 2021, 17:27
/report/000119248221000728-henwood-geraldine-2021-09-22 Baudax Bio, Inc. 22 Sep 2021 1 +$4,798 4 President and CEO, Director 23 Sep 2021, 16:10
/report/000119248221000407-henwood-geraldine-2021-05-07 Baudax Bio, Inc. 07 May 2021 1 +$4,992 4 President and CEO, Director 10 May 2021, 16:12
/report/000119248221000431-henwood-geraldine-2021-04-20-restatement Recro Pharma, Inc. 20 Apr 2021 1 $0 4/A Director 17 May 2021, 16:04